Blastoid mantle cell lymphoma in a patient with chronic myeloproliferative neoplasia
Hematol., Transfus. Cell Ther. (Impr.); 45 (1), 2023
Results: 15
Lymphomatous Polyposis: Case Report and Literature Review
Rev. colomb. gastroenterol; 37 (1), 2022
Abstract Lymphomatous polyposis (LP) is the endoscopic feature of primary gastrointestinal mantle cell lymphoma (MCL), a rare type of B-cell non-Hodgkin's lymphoma (NHL) and a typical but rare endoscopic pattern of gastrointestinal tract involvement (GIT) by nodal MCL. We present the case of a 62-year-ol...
Blastoid mantle cell lymphoma: cutaneous infiltration
An. bras. dermatol; 96 (4), 2021
Abstract Mantle cell lymphoma is an aggressive B-cell, non-Hodgkin's lymphoma, with lymph node or extranodal origin, and a mean survival of three to five years. Skin involvement is rare, secondary and indicates neoplasia dissemination. The authors report a case of a female patient, 69 years old, diagnose...
Mantle cell lymphoma presenting with lethal atraumatic splenic rupture
Autops. Case Rep; 11 (), 2021
Mantle cell lymphoma is characterized by t(11;14) with CCND1-IGH fusion and manifests with a spectrum of disease ranging from relatively indolent to aggressive. Here, we present a case of pleomorphic mantle cell lymphoma with three fusion signals that presented with lethal atraumatic splenic rupture. We ...
How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation
Hematol., Transfus. Cell Ther. (Impr.); 42 (2), 2020
ABSTRACT: The novel Coronavirus (CoVid-19) outbreak is now consider a world pandemic, affecting more than 1,300,000 people worldwide. Cancer patients are in risk for severe disease, including a higher risk of intensive care unit (ICU) admission, need for invasive ventilation or death. Management of patie...
Non-indolent mantle cell lymphoma at a single public hospital in Brazil: real world first-line treatment cohort study data
Hematol., Transfus. Cell Ther. (Impr.); 42 (1), 2020
Angiogênese e prognóstico em linfoma de células do manto
INTRODUÇÃO: Fatores prognósticos em Linfoma de Células do Manto (LCM) foram definidos em época sem padronização de tratamento e menos conhecimento de patogenia. Entre estes conhecimentos a participação da angiogênese ainda tem sido pouco estudada. Assim, a identificação de novos fatores progn...
Resultados de pacientes con linfoma del manto: impacto de terapias basadas en citarabina y trasplante hematopoyético
Rev. méd. Chile; 147 (1), 2019
Background: Mantle cell lymphoma (MCL) has high relapse and mortality rates. There is a survival benefit when treatment is intensified with cytarabine (AraC), hematopoietic cell transplantation (HCT) and maintenance with rituximab. Aim: To assess the outcomes of patients with MCL treated in a university...
Antimetabolitos Antineoplásicos/uso terapéutico, Antineoplásicos Inmunológicos/uso terapéutico, Citarabina/uso terapéutico, Trasplante de Células Madre Hematopoyéticas/métodos, Linfoma de Células del Manto/tratamiento farmacológico, Linfoma de Células del Manto/cirugía, Rituximab/uso terapéutico, Distribución por Edad, Terapia Combinada, Estimación de Kaplan-Meier, Linfoma de Células del Manto/mortalidad, Recurrencia Local de Neoplasia, Supervivencia sin Progresión, Estudios Retrospectivos, Factores de Riesgo, Distribución por Sexo, Estadísticas no Paramétricas, Factores de Tiempo, Resultado del Tratamiento
Linfoma de células del manto. Factores pronósticos: aportes de la anatomía patológica
Mantle cell lymphoma. Prognostic factors: contributions from pathological anatomy
Bol. Acad. Nac. Med. B.Aires; 96 (1-2), 2018
Characteristics of follicular and mantle cell lymphoma in Brazil: prognostic impact of clinical parameters and treatment conditions in two hospitals
Hematol., Transfus. Cell Ther. (Impr.); 40 (4), 2018
ABSTRACT Objective: Follicular and mantle cell lymphoma are low-grade B-cell malignancies that lack good responses to chemoimmunotherapy. This study aimed to assess retrospectively clinicopathological features and to determine independent prognostic factors for follicular and mantle cell lymphoma patien...